Pharmaceuticals & Medical Research

Amgen rebounds to $410.24 as dazodalibep and IMDELLTRA strengthen the pipeline while $418.73 becomes the next technical test.

TradingKey - On September 21, US-listed stocks tied to Greenland resources surged in pre-market trading. Greenland Energy (GLND) soared over 220% at one point, Greenland Mines (GRML) rose by nearly 130% at its peak, and Critical Metals (CRML) surged more than 37%. Market attention is refocusing on Greenland's resource development potential, with the sharp rally in related stocks linked to a recent security agreement reached among the United States, Denmark, and Greenland.

TradingKey - On Monday, September 21, Eastern Time, futures on the three major US stock indices all rose in pre-market trading as high-level US-China talks sent positive signals. Meanwhile, Brent crude fell for the fourth consecutive trading session, temporarily easing market concerns over energy prices driving inflation.

TradingKey - On September 21, Novo Nordisk (NVO) shares fell more than 7% in US pre-market trading at one point. The company's latest financial results showed that while its full-year sales and profit guidance improved from previous forecasts, sales performance of its core weight-loss drug Wegovy still fell short of market expectations, becoming the primary factor weighing on the stock.

TradingKey - As Capital Markets Day approaches, Novo Nordisk (NVO) is facing mounting pressure from institutional investors.

TradingKey - On September 16, Novo Nordisk (NVO) announced a partnership with artificial intelligence company Anthropic to leverage Claude and related AI models to support drug discovery and development, while further advancing the application of AI in scientific research and software development.